Market Research Logo

Global Myelodysplastic Syndrome Therapeutics Market 2018-2022

Global Myelodysplastic Syndrome Therapeutics Market 2018-2022

About Myelodysplastic Syndrome Therapeutics

Myelodysplastic syndrome (MDS) includes a group of clonal myeloid neoplasms characterized by cytopenia due to ineffective hematopoiesis, abnormal blood and marrow cell morphology, and a risk of clonal evolution and progression to AML.

Technavio’s analysts forecast the global myelodysplastic syndrome therapeutics market to grow at a CAGR of 2.54% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global myelodysplastic syndrome therapeutics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of patented and generic drugs used to treat MDS.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Myelodysplastic Syndrome Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Celgene
  • Otsuka
  • Novartis
Market driver
  • Improved prognostic classification of MDS through advanced technologies
  • For a full, detailed list, view our report
Market challenge
  • Inadequacies in treatment landscape of MDS
  • For a full, detailed list, view our report
Market trend
  • High incidence in older adult population
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Global oncology market
      • Table Parent market: The global oncology market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline Analysis
    • MDS Pipeline
      • Table Drugs approved by US FDA for MDS
      • Table Drugs approved by European Medicines Agency (EMA) for MDS
      • Table MDS pipeline phase II development stage agents
      • Table MDS pipeline phase III development stage agents
  • Market sizing
    • Market definition
      • Table Treatment Algorithm in MDS
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global MDS therapeutics market - Market size and forecast 2017-2022 ($ bn)
      • Table Global MDS therapeutics market - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by route of administration
    • Segmentation by ROA
      • Table Global MDS therapeutics market by ROA - Market share 2017-2022 (%)
    • Comparison by ROA
      • Table Comparison by ROA
    • Oral drugs - Market size and forecast 2017-2022
      • Table Oral drugs - Market size and forecast 2017-2022 ($ bn)
      • Table Oral drugs - Year-over-year growth 2018-2022 (%)
    • Parenteral Drugs - Market size and forecast 2017-2022
      • Table Parenteral drugs - Market size and forecast 2017-2022 ($ bn)
      • Table Parenteral drugs - Year-over-year growth 2018-2022 (%)
    • Market opportunity by route of administration
      • Table Market opportunity by route of administration
  • Market segmentation by sub-type of MDS
    • Segmentation by sub-type of MDS
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global MDS therapeutics market by geography - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ bn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • High cost of disease-management
    • High incidence in older adult population
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
      • Table Vendor classification
    • Celgene
      • Table Celgene overview
      • Table Celgene- Business segments
      • Table Celgene - Organizational developments
      • Table Celgene - Geographic focus
      • Table Celgene - Segment focus
      • Table Celgene - Key Offerings
    • Otsuka
      • Table Otsuka overview
      • Table Otsuka - Business segments
      • Table Otsuka - Organizational developments
      • Table Otsuka - Geographic focus
      • Table Otsuka - Segment focus
      • Table Otsuka- Key offerings
    • Novartis
      • Table Novartis overview
      • Table Novartis - Business segments
      • Table Novartis - Organizational developments
      • Table Novartis - Geographic focus
      • Table Novartis - Segment focus
      • Table Novartis - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report